-
261
Octodon degus laboratory colony management principles and methods for behavioral analysis for Alzheimer’s disease neuroscience research
Published 2025-01-01Subjects: Get full text
Article -
262
The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
Published 2025-02-01Subjects: “…Alzheimer’s disease…”
Get full text
Article -
263
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer’s Disease: A Comprehensive Review
Published 2022-01-01“…Alzheimer’s disease (AD) is the most common form of dementia affecting millions of individuals, including family members who often take on the role as caregiver. …”
Get full text
Article -
264
Alterations in mRNA level of proteins related to redox state and mitochondria in an Alzheimer’s disease animal model: Promising targets in neuroprotection
Published 2024-10-01Subjects: “…alzheimer’s disease…”
Get full text
Article -
265
Functional MRI Assessment of Task-Induced Deactivation of the Default Mode Network in Alzheimer’s Disease and At-Risk Older Individuals
Published 2009-01-01“…Alzheimer’s disease (AD) is the most common form of dementia in old age, and is characterized by prominent impairment of episodic memory. …”
Get full text
Article -
266
Impact of Aluminium Chloride (AlCl₃) on Brain Function: A Review of Neurotoxic Mechanisms and Implications for Alzheimer's Disease
Published 2024-12-01Subjects: Get full text
Article -
267
Nanoparticle Therapy Is a Promising Approach in the Management and Prevention of Many Diseases: Does It Help in Curing Alzheimer Disease?
Published 2020-01-01“…Primary research studies in using nanoparticles to cure Alzheimer disease (AD) are promising but are still in need for more investigations. …”
Get full text
Article -
268
Uncovering the molecular mechanisms behind Alzheimer’s and Parkinson’s disease through multi-omics: an interview with Bruno A. Benitez
Published 2025-01-01Subjects: Get full text
Article -
269
Neural mechanisms of non-pharmacological interventions in patients with mild cognitive impairment and Alzheimer's disease: An ALE meta-analysis
Published 2025-02-01Subjects: Get full text
Article -
270
Alzheimer’s Disease as a Result of Stimulus Reduction in a GABA-A-Deficient Brain: A Neurocomputational Model
Published 2020-01-01“…Several research studies point to the fact that sensory and cognitive reductions like cataracts, deafness, macular degeneration, or even lack of activity after job retirement, precede the onset of Alzheimer’s disease. To simulate Alzheimer’s disease earlier stages, which manifest in sensory cortices, we used a computational model of the koniocortex that is the first cortical stage processing sensory information. …”
Get full text
Article -
271
Icariin Promotes Survival, Proliferation, and Differentiation of Neural Stem Cells In Vitro and in a Rat Model of Alzheimer’s Disease
Published 2021-01-01“…Alzheimer’s disease (AD) involves the degeneration of cholinergic neurons in the basal forebrain. …”
Get full text
Article -
272
Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum
Published 2025-02-01Subjects: “…Alzheimer’s disease…”
Get full text
Article -
273
-
274
Preclinical Cognitive Markers of Alzheimer Disease and Early Diagnosis Using Virtual Reality and Artificial Intelligence: Literature Review
Published 2025-01-01“… Abstract BackgroundThis review explores the potential of virtual reality (VR) and artificial intelligence (AI) to identify preclinical cognitive markers of Alzheimer disease (AD). By synthesizing recent studies, it aims to advance early diagnostic methods to detect AD before significant symptoms occur. …”
Get full text
Article -
275
Metabolic Risk Factors of Alzheimer’s Disease, Dementia with Lewy Bodies, and Normal Elderly: A Population-Based Study
Published 2018-01-01“…Background. Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB) share many risk factors. …”
Get full text
Article -
276
Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation
Published 2014-01-01“…Additionally, acetylcholinesterase (AChE) is the target for many Alzheimer’s dementia drugs which block the function of AChE but have some side effects. …”
Get full text
Article -
277
HEDDI-Net: heterogeneous network embedding for drug-disease association prediction and drug repurposing, with application to Alzheimer’s disease
Published 2025-02-01Subjects: Get full text
Article -
278
Toward a new interdisciplinary model to understand Alzheimer’s disease: The interplay between neurobiology and socio-economic factors
Published 2018-11-01Subjects: “…Neuroinflammation; Alzheimer’s disease; air pollution; PM2.5; eco-politics; education; models…”
Get full text
Article -
279
Influence of immune cells and inflammatory factors on Alzheimer’s disease axis: evidence from mediation Mendelian randomization study
Published 2025-02-01Subjects: Get full text
Article -
280
Using Propensity Score Matching Technique to Estimate Utilization and Costs of General Practitioners’ Services associated with Alzheimer’s Disease
Published 2016-03-01“…**Objective:** General practitioners (GPs) play an important role in caring for people with Alzheimer’s disease (AD). However, the cost and the extent of service utilization from GPs due to AD patients are difficult to assess. …”
Get full text
Article